Q&A Genmab 2021-08-26

	26/8 13:31 af Jan Van de Winkel	No - it has been shown to be notorious difficult to vaccinate against cancers (both prophylactically and therapeutically)..
	26/8 13:32 af Jan Van de Winkel	Novel developments in the mRNA field are focussing on use of mRNA based delivery of larger proteins to patients. This is an area we are very actively involved in in our laboratories, as well as in interaction with CureVac to explore if mRNA can be used for delivery of therapeutic antibodies.
	26/8 13:33 af kkjoel	Mr Winkel, can you help us understand what the new drug DuoBody-CD3xB7H4 (GEN1047) is all about, mechanisms, disease indications, and so on....
	26/8 13:35 af Jan Van de Winkel	Trouble sending..
	26/8 13:36 af Jan Van de Winkel	This is a novel concept aiming to activate killer cells of the immune system
	26/8 13:36 af Jan Van de Winkel	..
	26/8 13:36 af Jan Van de Winkel	to different solid cancers. We have already shown that this new bispecific antibody concept works excellently in the laboratory and very soon we hope to start testing DuoBody CD3xB7H4 in a number of solid cancers.
	26/8 13:38 af Jan Van de Winkel	The existing ADR program was a 10-1 split and we decided to keep the same ratio to be consistent.
	26/8 13:39 af Helge Larsen/PI-redaktør	And now to the last question.
	26/8 13:39 af kkjoel	Mr Winkel, at the cc you were asked several times about the data presentations (and acceptance hereof) at conferences this autumn - might there be a little news-goodie for us, your loyal PI-troops - on that front?
	26/8 13:40 af Jan Van de Winkel	We expect some very lively and energizing months ahead as it relates to data presentations on multiple programs from Genmab, so stay tuned.
	26/8 13:41 af Helge Larsen/PI-redaktør	Thank you for joining us and thank you for the many fullfilling answers to our questions. We look forward to seeing you back here on ProInvestor.com after Q3.
	26/8 13:41 af Jan Van de Winkel	Thank you all for an exciting session. Stay safe, keep optimistic and looking forward to speak soon.
	26/8 13:41 af Helge Larsen/PI-redaktør	This session have ended.
	2/9 11:35 af Helge Larsen/PI-redaktør	Vestas får godt nyt fra Australien: "Et historisk øjeblik" (link)